Epigenetic modifiers have fundamental roles in defining unique cellular identity through the establishment and maintenance of lineage-specific chromatin and methylation status1. Several DNA modifications such as 5-hydroxymethylcytosine (5hmC) are catalysed by the ten eleven translocation (Tet) methylcytosine dioxygenase family members2, and the roles of Tet proteins in regulating chromatin architecture and gene transcription independently of DNA methylation have been gradually uncovered3. However, the regulation of immunity and inflammation by Tet proteins independent of their role in modulating DNA methylation remains largely unknown. Here we show that Tet2 selectively mediates active repression of interleukin-6 (IL-6) transcription during inflammation resolution in innate myeloid cells, including dendritic cells and macrophages. Loss of Tet2 resulted in the upregulation of several inflammatory mediators, including IL-6, at late phase during the response to lipopolysaccharide challenge. Tet2-deficient mice were more susceptible to endotoxin shock and dextran-sulfate-sodium-induced colitis, displaying a more severe inflammatory phenotype and increased IL-6 production compared to wild-type mice. IκBζ, an IL-6-specific transcription factor, mediated specific targeting of Tet2 to the Il6 promoter, further indicating opposite regulatory roles of IκBζ at initial and resolution phases of inflammation. For the repression mechanism, independent of DNA methylation and hydroxymethylation, Tet2 recruited Hdac2 and repressed transcription of Il6 via histone deacetylation. We provide mechanistic evidence for the gene-specific transcription repression activity of Tet2 via histone deacetylation and for the prevention of constant transcription activation at the chromatin level for resolving inflammation.

No abstract

CD8α(+) dendritic cells (DCs) are specialized at cross-presenting extracellular antigens on major histocompatibility complex (MHC) class I molecules to initiate cytotoxic T lymphocyte (CTL) responses; however, details of the mechanisms that regulate cross-presentation remain unknown. We found lower expression of the lectin family member Siglec-G in CD8α(+) DCs, and Siglec-G deficient (Siglecg(-/-)) mice generated more antigen-specific CTLs to inhibit intracellular bacterial infection and tumor growth. MHC class I-peptide complexes were more abundant on Siglecg(-/-) CD8α(+) DCs than on Siglecg(+/+) CD8α(+) DCs. Mechanistically, phagosome-expressed Siglec-G recruited the phosphatase SHP-1, which dephosphorylated the NADPH oxidase component p47(phox) and inhibited the activation of NOX2 on phagosomes. This resulted in excessive hydrolysis of exogenous antigens, which led to diminished formation of MHC class I-peptide complexes for cross-presentation. Therefore, Siglec-G inhibited DC cross-presentation by impairing such complex formation, and our results add insight into the regulation of cross-presentation in adaptive immunity.

RuO2/SnO2 catalysts with 2, 5 and 10 % Ru loadings were prepared with calcined and uncalcined SnO2 supports by the impregnation method. The catalysts were evaluated for CO and CH4 oxidation and characterised by N2‐BET, XRD, hydrogen temperature programmed reduction (H2‐TPR), energy‐dispersive X‐ray spectroscopy scanning electron microscopy (EDS‐SEM) and thermogravimetric analysis differential scanning calorimetry (TGA‐DSC). Owing to the synergetic effect between RuO2 and SnO2, all RuO2/SnO2 catalysts are found to be much more active than pure SnO2 and RuO2/Al2O3 for both CO and CH4 oxidation. For RuO2 supported on uncalcined SnO2, H2‐TPR and TGA‐DSC analysis revealed the formation of a new, less active compound between Sn and Ru that consumed active SnO2 and RuO2, and could be detrimental to the synergism between RuO2 and SnO2, and thus the activity of RuO2/SnO2 catalytic system. As a consequence, it is much less active than RuO2 supported on calcined SnO2. RuO2/SnO2 catalysts are also very stable in the presence of water vapour, which gives them potential for application in after‐treatment processes.

MNPs@MOF catalysts obtained by encapsulating metal nanoparticles (NPs) into metal–organic frameworks (MOFs) show fascinating performance in heterogeneous catalysis. The improvement of catalytic activity and reusability of MNPs@MOF catalysts has been a great challenge for a long time. Herein, we demonstrate well-designed Pd/MOFs, featuring hollow double-shell structure and magnetic property, exhibiting high reusability, efficient catalytic activity, and size selectivity for hydrogenation reaction. The as-synthesized Pd/MOF, denoted as Void nFe3O4@Pd/ZIF-8@ZIF-8, possesses diverse functional structural features. The hollow cavity can improve mass transfer; superparamagnetic Fe3O4 NPs embedded in the inner MOF shell can enhance the separation and recyclability; Pd NPs are highly dispersed in the matrix of the inner MOF shell, and the outer MOF shell acts as a protector to prevent the leaching of Pd NPs and a sieve to achieve size selectivity. As a proof of concept, the Void nFe3O4@Pd/ZIF-8@ZIF-8 catalyst exhibited excellent performance for the hydrogenation of styrene at room temperature. The activity only reduced 10% after 20 cycles for the higher conversions (>90%), and the lower conversion only decreased 3.6% (from 32.5 to 28.9% conversion) after twenty consecutive cycles, indicating the good and intrinsic reusability of the catalyst. The proposed structure in this work provides a strategy to effectively improve the reusability of MNPs@MOF catalysts, which would increase their practical applications.